Literature DB >> 26077389

Structural characterization of human galectin-4 C-terminal domain: elucidating the molecular basis for recognition of glycosphingolipids, sulfated saccharides and blood group antigens.

Khuchtumur Bum-Erdene1, Hakon Leffler2, Ulf J Nilsson3, Helen Blanchard1.   

Abstract

Human galectin-4 is a lectin that is expressed mainly in the gastrointestinal tract and exhibits metastasis-promoting roles in some cancers. Its tandem-repeat nature exhibits two distinct carbohydrate recognition domains allowing crosslinking by simultaneous binding to sulfated and non-sulfated (but not sialylated) glycosphingolipids and glycoproteins, facilitating stabilization of lipid rafts. Critically, galectin-4 exerts favourable or unfavourable effects depending upon the cancer. Here we report the first X-ray crystallographic structural information on human galectin-4, specifically the C-terminal carbohydrate recognition domain of human (galectin-4C) in complex with lactose, lactose-3'-sulfate, 2'-fucosyllactose, lacto-N-tetraose and lacto-N-neotetraose. These structures enable elucidation of galectin-4C binding fine-specificity towards sulfated and non-sulfated lacto- and neolacto-series sphingolipids as well as to human blood group antigens. Analysis of the lactose-3'-sulfate complex structure shows that galectin-4C does not recognize the sulfate group using any specific amino acid, but binds the ligand nonetheless. Complex structures with lacto-N-tetraose and lacto-N-neotetraose displayed differences in binding interactions exhibited by the non-reducing-end galactose. That of lacto-N-tetraose points outward from the protein surface whereas that of lacto-N-neotetraose interacts directly with the protein. Recognition patterns of human galectin-4C towards lacto- and neolacto-series glycosphingolipids are similar to those of human galectin-3; however, detailed scrutiny revealed differences stemming from the extended binding site that offer distinction in ligand profiles of these two galectins. Structural characterization of the complex with 2'-fucosyllactose, a carbohydrate with similarity to the H antigen, and molecular dynamics studies highlight structural features that allow specific recognition of A and B antigens, whilst a lack of interaction with the 2'-fucose of blood group antigens was revealed. DATABASE ACCESSION CODES: 4YLZ, 4YM0, 4YM1, 4YM2, 4YM3.
© 2015 FEBS.

Entities:  

Keywords:  blood group antigen; crystal structure; galectin-4; glycosphingolipid; oligosaccharide

Mesh:

Substances:

Year:  2015        PMID: 26077389     DOI: 10.1111/febs.13348

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  15 in total

1.  Tumor cells interact with red blood cells via galectin-4 - a short report.

Authors:  Reham Helwa; Anette Heller; Stian Knappskog; Andrea S Bauer
Journal:  Cell Oncol (Dordr)       Date:  2017-03-14       Impact factor: 6.730

2.  Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.

Authors:  Mathias Ingemann Nielsen; John Stegmayr; Oliver C Grant; Zhang Yang; Ulf J Nilsson; Irene Boos; Michael C Carlsson; Robert J Woods; Carlo Unverzagt; Hakon Leffler; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

3.  Dissecting Context-Specific Galectin Binding Using Glycoengineered Cell Libraries.

Authors:  Mathias Ingemann Nielsen; Hans H Wandall
Journal:  Methods Mol Biol       Date:  2022

Review 4.  The role of galectin-4 in physiology and diseases.

Authors:  Zhan-Qi Cao; Xiu-Li Guo
Journal:  Protein Cell       Date:  2016-03-26       Impact factor: 14.870

5.  Full-length model of the human galectin-4 and insights into dynamics of inter-domain communication.

Authors:  Joane K Rustiguel; Ricardo O S Soares; Steve P Meisburger; Katherine M Davis; Kristina L Malzbender; Nozomi Ando; Marcelo Dias-Baruffi; Maria Cristina Nonato
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

6.  Structure-based rationale for differential recognition of lacto- and neolacto- series glycosphingolipids by the N-terminal domain of human galectin-8.

Authors:  Mohammad H Bohari; Xing Yu; Yehiel Zick; Helen Blanchard
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 7.  Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Authors:  Kamil Wdowiak; Tomasz Francuz; Enrique Gallego-Colon; Natalia Ruiz-Agamez; Marcin Kubeczko; Iga Grochoła; Jerzy Wojnar
Journal:  Int J Mol Sci       Date:  2018-01-10       Impact factor: 5.923

8.  Exploring functional pairing between surface glycoconjugates and human galectins using programmable glycodendrimersomes.

Authors:  Qi Xiao; Anna-Kristin Ludwig; Cecilia Romanò; Irene Buzzacchera; Samuel E Sherman; Maria Vetro; Sabine Vértesy; Herbert Kaltner; Ellen H Reed; Martin Möller; Christopher J Wilson; Daniel A Hammer; Stefan Oscarson; Michael L Klein; Hans-Joachim Gabius; Virgil Percec
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

9.  Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactose.

Authors:  Khuchtumur Bum-Erdene; Hakon Leffler; Ulf J Nilsson; Helen Blanchard
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Chicken GRIFIN: Structural characterization in crystals and in solution.

Authors:  Federico M Ruiz; Ulrich Gilles; Anna-Kristin Ludwig; Celia Sehad; Tze Chieh Shiao; Gabriel García Caballero; Herbert Kaltner; Ingo Lindner; René Roy; Dietmar Reusch; Antonio Romero; Hans-Joachim Gabius
Journal:  Biochimie       Date:  2017-12-15       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.